Ventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Ventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-09-11FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approves Apotex Corp.'s supplemental application for sotalol hydrochloride, enabling a generic version of the antiarrhythmic for clinica…
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Preventive VT Substrate Ablation in Ischemic Heart Disease [Phase 3]
Phase 3 clinical trial update on preventive substrate ablation for ventricular tachycardia in ischemic heart disease (status: unknown).
-
FDA approval · 2023-02-21FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic Propafenone hydrochloride product from Aurobindo Pharma Limited under an Original Application. This marks market entr…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia [NA]
Clinical trial update on intramural needle ablation for recurrent ventricular tachycardia; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial [NA]
A completed clinical trial update for a catheter ablation trial targeting prevention of sudden cardiac death in ventricular tachycardia pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation [Phase 3]
A Phase 3 trial studying continuation of antiarrhythmic therapy after ventricular tachycardia catheter ablation was terminated; results post…
-
CLINICAL_TRIALS trial_result · 2022-11-01Clinical Trial Update: Bipolar Ventricular Tachycardia (VT) Study [NA]
Completed clinical trial on ventricular tachycardia with results posted.
-
FDA approval · 2022-10-25FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for sotalol hydrochloride by Teva Pharmaceuticals USA, Inc., indicating regulatory approval of a…
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: Magnetic Stimulation to Treat VT Storm [NA]
A completed clinical trial evaluating magnetic stimulation as a treatment for ventricular tachycardia storm, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Tachy Prediction Download Study
Completed clinical trial update for a tachy prediction study in ventricular tachycardia; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: Stereotactic Ablative Radiotherapy for Refractory Ventricular Tachycardia [NA]
Completed clinical trial evaluating stereotactic ablative radiotherapy for refractory ventricular tachycardia; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: GANGlion Stellate Block for Treatment of Electric storRm (GANGSTER Trial) [Phase 3]
Phase 3 clinical trial update for GANGlion Stellate Block therapy targeting ventricular arrhythmias, including ventricular tachycardia and r…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation [Phase 4]
Phase 4 clinical trial update evaluating direct oral anticoagulants for stroke prevention after ventricular tachycardia ablation; results po…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Introductory Clinical Trial for Measuring Patients Before, During, and After an Electrophysiology (EP) Procedure With a Novel, Body-Worn Sensor [NA]
A completed clinical trial evaluating a novel body-worn sensor to measure patients before, during, and after an EP procedure in atrial fibri…
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead [NA]
This clinical trial update reports completion and posted results for a Septal implant of a ventricular defibrillation lead, focusing on outc…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: An Assessment of Dual Site Left Ventricular Endocardial Pacing [NA]
A completed clinical trial assessing dual site left ventricular endocardial pacing in patients with atrial fibrillation and ventricular tach…
-
FDA approval · 2021-02-04FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for sotalol hydrochloride by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System. [NA]
A completed clinical trial evaluating the iD-System One-Handed Disposable Internal Defibrillation System is reported, with results posted in…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Imaging With a Radio Tracer to Guide VT Ablations [NA]
A completed clinical trial evaluating imaging with a radiotracer to guide ventricular tachycardia ablations; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Vest Prevention of Early Sudden Death Trial and VEST Registry [NA]
Clinical trial update for the Vest Prevention of Early Sudden Death Trial and VEST Registry, completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction [NA]
Boston Scientific's EMBLEM S-ICD was studied for primary prevention in patients with low ejection fraction, and the trial results were poste…
-
FDA approval · 2020-09-16FDA Approved: FLECAINIDE ACETATE — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved flecainide acetate from Unichem Pharmaceuticals (USA), Inc. as an original ANDA (210683) for the treatment of documented tachya…
-
FDA approval · 2020-07-21FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved the Original Application for Amiodarone Hydrochloride from Unichem Pharmaceuticals (USA), Inc., confirming regulatory appro…
-
FDA approval · 2020-07-15FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for amiodarone hydrochloride (Chartwell RX, LLC).
-
FDA approval · 2020-06-23FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited.